Authors:
Peters-Engl, C
Frank, W
Kerschbaum, F
Denison, U
Medl, M
Sevelda, P
Citation: C. Peters-engl et al., Lunar phases and survival of breast cancer patients - a statistical analysis of 3,757 cases, BREAST CANC, 70(2), 2001, pp. 131-135
Authors:
Obermair, A
Geramou, M
Gucer, F
Denison, U
Graf, AH
Kapshammer, E
Medl, M
Rosen, A
Wierrani, F
Neunteufel, W
Frech, I
Preyer, O
Speiser, P
Kainz, C
Citation: A. Obermair et al., Impact of hysteroscopy on disease-free survival in clinically stage I endometrial cancer patients, INT J GYN C, 10(4), 2000, pp. 275-279
Authors:
Huber, S
Danes, J
Zuna, I
Teubner, J
Medl, M
Delorme, S
Citation: S. Huber et al., Relevance of sonographic B-mode criteria and computer-aided ultrasonic tissue characterization in differential/diagnosis of solid breast masses, ULTRASOUN M, 26(8), 2000, pp. 1243-1252
Authors:
Huber, S
Medl, M
Helbich, T
Taucher, S
Wagner, T
Rudas, M
Zuna, I
Delorme, S
Citation: S. Huber et al., Locally advanced breast carcinoma: Computer assisted semiquantitative analysis of color Doppler ultrasonography in the evaluation of tumor response to neoadjuvant chemotherapy (work in progress), J ULTR MED, 19(9), 2000, pp. 601-607
Authors:
Huber, S
Medl, M
Vesely, M
Czembirek, H
Zuna, I
Delorme, S
Citation: S. Huber et al., Ultrasonographic tissue characterization in monitoring tumor response to neoadjuvant chemotherapy in locally advanced breast cancer (work in progress), J ULTR MED, 19(10), 2000, pp. 677-686
Authors:
Medl, M
Peters-Engl, C
Schutz, P
Vesely, M
Sevelda, P
Citation: M. Medl et al., First report of lymphatic mapping with isosulfan blue dye and sentinel node biopsy in cervical cancer, ANTICANC R, 20(2B), 2000, pp. 1133-1134
Authors:
Huber, S
Wagner, M
Zuna, I
Medl, M
Czembirek, H
Delorme, S
Citation: S. Huber et al., Locally advanced breast carcinoma: Evaluation of mammography in the prediction of residual disease after induction chemotherapy, ANTICANC R, 20(1B), 2000, pp. 553-558
Authors:
Obermair, A
Geramou, M
Gucer, F
Denison, U
Graf, AH
Kapshammer, E
Medl, M
Rosen, A
Wierrani, F
Neunteufel, W
Frech, I
Speiser, P
Kainz, C
Breitenecker, G
Citation: A. Obermair et al., Endometrial cancer: accuracy of the finding of a well differentiated tumorat dilatation and curettage compared to the findings at subsequent hysterectomy, INT J GYN C, 9(5), 1999, pp. 383-386
Authors:
Peters-Engl, C
Frank, W
Danmayr, E
Friedl, HP
Leodolter, S
Medl, M
Citation: C. Peters-engl et al., Association between endometrial cancer and tamoxifen treatment of breast cancer, BREAST CANC, 54(3), 1999, pp. 255-260
Authors:
Peters-Engl, C
Frank, W
Leodolter, S
Medl, M
Citation: C. Peters-engl et al., Tumor flow in malignant breast tumors measured by Doppler ultrasound: an independent predictor of survival, BREAST CANC, 54(1), 1999, pp. 65-71
Authors:
Peters-Engl, C
Obermair, A
Heinzl, H
Buxbaum, P
Sevelda, P
Medl, M
Citation: C. Peters-engl et al., CA 125 regression after two completed cycles of chemotherapy: lack of prediction for long-term survival in patients with advanced ovarian cancer, BR J CANC, 81(4), 1999, pp. 662-666
Authors:
Peters-Engl, C
Buxbaum, P
Ogris, E
Sevelda, P
Medl, M
Citation: C. Peters-engl et al., TATI (tumor associated trypsin inhibitor) and cancer antigen 125 (CA 125) in patients with early-stage endometrial cancer, ANTICANC R, 18(6B), 1998, pp. 4635-4639